PESCINI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.631
EU - Europa 2.545
AS - Asia 1.516
SA - Sud America 148
AF - Africa 31
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.900
Nazione #
US - Stati Uniti d'America 3.588
RU - Federazione Russa 1.010
SG - Singapore 482
PL - Polonia 466
CN - Cina 381
IT - Italia 323
HK - Hong Kong 259
SE - Svezia 207
IE - Irlanda 201
KR - Corea 135
BR - Brasile 121
DE - Germania 85
VN - Vietnam 81
FI - Finlandia 80
GB - Regno Unito 55
IN - India 54
FR - Francia 52
JO - Giordania 36
CA - Canada 29
AU - Australia 28
UA - Ucraina 19
TR - Turchia 18
AR - Argentina 16
ID - Indonesia 15
JP - Giappone 15
ES - Italia 11
CI - Costa d'Avorio 10
NL - Olanda 10
MX - Messico 9
ZA - Sudafrica 9
BD - Bangladesh 8
CZ - Repubblica Ceca 7
LT - Lituania 6
BE - Belgio 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
IQ - Iraq 4
UZ - Uzbekistan 4
MA - Marocco 3
OM - Oman 3
BY - Bielorussia 2
EG - Egitto 2
HN - Honduras 2
KG - Kirghizistan 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 7.900
Città #
Santa Clara 708
Warsaw 466
Ashburn 409
Fairfield 348
Singapore 300
Chandler 235
Hong Kong 218
Dublin 201
Woodbridge 184
Houston 143
Seattle 139
Seoul 135
Cambridge 134
Beijing 130
Wilmington 116
Florence 81
Hefei 75
Altamura 70
Lawrence 67
Los Angeles 59
Princeton 58
Ann Arbor 57
Moscow 50
Buffalo 44
Jacksonville 44
Paris 40
Boston 37
Mumbai 36
Munich 36
Ho Chi Minh City 33
New York 31
Melbourne 28
Shanghai 24
Turku 24
Medford 23
Kent 20
Boardman 19
Helsinki 18
San Diego 18
Clifton 15
Dallas 15
Tokyo 15
Izmir 14
London 14
São Paulo 12
Toronto 12
Denver 11
Jakarta 11
Abidjan 10
Falls Church 10
Hanoi 10
Redondo Beach 10
Chicago 9
Johannesburg 9
Norwalk 9
Rome 9
Phoenix 8
The Dalles 8
Dong Ket 7
Frankfurt am Main 7
Orem 7
Yubileyny 7
Andover 6
Barcelona 6
Brno 6
Brooklyn 6
Chennai 6
Dearborn 6
Hillsboro 6
Manchester 6
Montreal 6
Poplar 6
Stockholm 6
Atlanta 5
Cantù 5
Falkenstein 5
Lappeenranta 5
Milan 5
Brasília 4
Cagliari 4
Chiesina Uzzanese 4
Guangzhou 4
Guarulhos 4
Hounslow 4
Tashkent 4
Verona 4
Zhengzhou 4
Belo Horizonte 3
Bengaluru 3
Biên Hòa 3
Charlotte 3
Council Bluffs 3
Detroit 3
Fiesole 3
Gallarate 3
Ghent 3
Haiphong 3
Mexico City 3
Muscat 3
Pescara 3
Totale 5.263
Nome #
Caratteristiche cliniche, profilo di rischio vascolare e profilo neuropsicologico dei pazienti affetti da leucoencefalopatia micro vascolare sporadica (età-correlata) e geneticamente determinata (CADASIL): Risultati preliminari del MIcrovascular LEukoencephalopaty Study (MILES) 245
CEREBRAL AUTOREGULATION IN THE EARLY STAGES OF CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY) 241
Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS) 232
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 225
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 215
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 203
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 189
Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL 188
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 187
APOE ε 2 is associated with white matter hyperintensity volume in CADASIL 177
Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. 170
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 167
CADASIL in central Italy: A retrospective clinical and genetic study in 229 patients 167
Bone marrow-derived progenitor cells in cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy 162
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 160
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 160
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 158
The CADASIL scale: a screening tool to select patients for NOTCH3 gene analysis 156
Cerebellar arteriovenous malformation and vertebral artery aneurysm in a CADASIL patient 155
European Stroke Organisation Conference: Abstracts 151
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 146
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 146
A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient 145
Intravenous thrombolysis in CADASIL: report of two cases and a systematic review 144
Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients 144
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 143
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 141
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 140
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 140
Familial cerebral cavernous malformation: report of a further Italian family 140
High lipoprotein(a) serum levels in three CADASIL families. 140
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 140
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 138
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 132
Ischemic stroke during cisplatin-based chemotherapy for testicular germ celltumor: case report and review of the literature. 132
Cerebral hemorrhages in CADASIL: report of four cases and a brief review. 131
Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia 128
Cardiac calcified amorphous tumor as a rare cause of ischemic stroke: Clinical case 128
Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial 126
Differential diagnosis between epilepsy and syncope. The Oesys study (overlapping between epilepsy and syncope study): Preliminary results 125
Functional Magnetic Resonance Imaging of Inhibitory Control Reveals Decreased Blood Oxygen Level Dependent Effect in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy 122
Letter by Pescini et al Regarding Article, "Peripheral Artery Disease as a Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) and Practical Implications". 120
Postpartum psychiatric disturbances as an unrecognized onset of CADASIL. 116
Psychiatric disturbances in CADASIL: a brief review 114
Mutation screening of HTRA1 gene in NOTCH3-negative patients with cerebral small vessel disease 114
Altered Regional Brain Homogeneity of BOLD Signal in CADASIL: A Resting State fMRI Study 113
Detection of subclinical atrial fibrillation after cryptogenic stroke using implantable cardiac monitors 113
Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial 111
High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. 106
Response to letter regarding article, “The cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy scale. A screening tool to select patients for NOTCH3 gene analysis” 100
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial 98
Exploring differences in Cerebral Small Vessel Disease: a comparative analysis of clinical, radiological and cognitive features of Cerebral Amyloid Angiopathy and Deep Perforator Arteriopathy 96
First report of a Romanian CADASIL patient following immigration to Italy 96
Genome-wide genotyping demonstrates a polygenic risk score associated with white matter hyperintensity volume in CADASIL 88
Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? 8
Totale 7.972
Categoria #
all - tutte 23.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 52 31 38 56 64 29 40
2021/2022295 11 24 12 8 5 27 11 24 11 19 44 99
2022/2023994 91 227 42 64 71 164 122 48 104 2 46 13
2023/2024407 11 40 58 19 40 51 14 99 6 22 25 22
2024/20252.560 100 321 161 421 620 300 43 183 110 82 90 129
2025/20261.641 369 401 185 242 386 58 0 0 0 0 0 0
Totale 7.972